Home / Inspections / 1228172

FDA Inspection 1228172 — Center for Fertility and Reproductive Endocrinology UPP

Center for Fertility and Reproductive Endocrinology UPP — FEI 3004081056

The FDA completed an inspection of Center for Fertility and Reproductive Endocrinology UPP on January 23, 2024 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 23, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Pittsburgh, PA (United States)

Facility

Other inspections at this facility

  • 1158607 (NAI Wed Dec 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1069130 (NAI Wed Aug 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027413 (NAI Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 972652 (VAI Thu May 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 937750 (NAI Wed Aug 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources